LINJARDY MXR 12.5/2.5/1000MG TAB NEW

LINJARDY MXR is a combination tablet containing Empagliflozin 12.5mg, Linagliptin 2.5mg, and Metformin HCL 1000mg. This triple-action formulation is designed to help manage type 2 diabetes by working through multiple mechanisms—reducing blood sugar through increased urination, enhancing insulin secretion, and improving insulin sensitivity. Each tablet combines the benefits of three proven antidiabetic agents in a single dose, supporting comprehensive glucose control. Suitable for patients requiring multi-drug therapy to achieve optimal diabetes management alongside diet and exercise.